Evidence map›Paper›PMID 34604412›Full record

ArticleReports of biochemistry & molecular biology2021

Evaluation of

Shaghayegh Pezeshki, Payam Hashemi, Alireza Salimi, Sheida Ebrahimi, Mandana Javanzad, Amir Monfaredan

Open access · goldAbstract read
In one paragraph

Article in Reports of biochemistry & molecular biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Shaghayegh PezeshkiDepartment of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Payam HashemiSchool of Medicine, Tehran University of Medical Science, Tehran, Iran.
Alireza SalimiDepartment of Molecular and Cellular Sciences, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Sheida EbrahimiDepartment of Genetic, Faculty of biology, Yazd University, Yazd, Iran.
Mandana JavanzadMedical Branch, Islamic Azad University, Tehran, Iran.
Amir MonfaredanDepartment of Hematology, Faculty of Medicine, Tabriz Branch, Islamic Azad University, Tabriz, Iran.
Islamic Azad University Medical Branch of Tehran · IRIran University of Medical Sciences · IRIslamic Azad University of Tabriz · IRUniversity of Tehran · IRYazd University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundProstate cancer (PC) is one of the most abundant cancers among men, and In Iran, has been responsible for 6% of all deaths from cancer in men.

methodsBiopsy samples from 40 PC patients and 41 healthy Iranian men were used to determine the relative gene expression. After RNA extraction and cDNA synthesis, samples were analyzed using TaqMan Quantitative Real time PCR. Patients' background information, included smoking habits and family histories of PC, were recorded. Stages and grades of their PC were classified by the TNM tumor, node, metastasis (TMN) staging system based on standard guidelines.

results

conclusionRegarding the significant role of

Indexed as

Family historyGeminin (GMNN)NUF2Prostate cancerTumor staging

Identifiers

PMID34604412
PMCPMC8480293
OpenAlexW3200038108

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.